Department of Chemical Sciences, Ariel University, Ariel, Israel.
Faculty of Chemistry, Weizmann Institute of Science, Rehovot, Israel.
Biotechnol Bioeng. 2022 Jul;119(7):1997-2003. doi: 10.1002/bit.28089. Epub 2022 Apr 4.
Immunoglobulin M (IgM) antibodies hold promise as anticancer drugs and as agents for promoting immune homeostasis. This promise has not been realized due to low expression levels in mammalian cells producing IgM class antibodies, and the failure of protein A chromatography for IgM purification. Here, we describe a nonchromatographic platform for quantitatively capturing IgMs at neutral pH, which is then recovered with 86%-94% yield and >95% purity at pH 3. The platform contains micelles conjugated with the [(bathophenanthroline) :Fe ] amphiphilic complex. Inclusion of amino acid monomers, for example, phenylalanine or tyrosine, during conjugation of detergent micelles, allows subsequent extraction of IgMs at close to neutral pH. With the successful implementation of this purification platform for both polyclonal humans and bovine IgMs, we anticipate similar results for monoclonal IgMs, most relevant for the pharmaceutical industry.
免疫球蛋白 M(IgM)抗体有望成为抗癌药物和促进免疫稳态的药物。由于在产生 IgM 类抗体的哺乳动物细胞中表达水平低,以及蛋白 A 层析法不能用于 IgM 纯化,这一承诺尚未实现。在这里,我们描述了一种在中性 pH 值下定量捕获 IgM 的非色谱平台,然后在 pH 值为 3 时以 86%-94%的收率和 >95%的纯度回收。该平台包含与 [(bathophenanthroline) :Fe ] 两亲性配合物偶联的胶束。在去污剂胶束的偶联过程中加入氨基酸单体,例如苯丙氨酸或酪氨酸,可以在接近中性 pH 值的条件下进行后续的 IgM 萃取。通过成功地将该纯化平台应用于多克隆人 IgM 和牛 IgM,我们预计单克隆 IgM 也会有类似的结果,这对制药行业最为重要。